The risk factor for adverse pregnancy outcomes and its impact on clinical effect in IgA nephropathy: A retrospective observational study.
Fengxia ZhangZhiyong XieSiqi PengNan JiangBohou LiBoxi ChenShuting DengYe YuanQiong WuSichun WenYiming TaoJianchao MaSijia LiTing LinFeng WenZhuo LiRenwei HuangZhonglin FengChaosheng HeWenjian WangXinling LiangLixia XuYue ShenNiechao HongRuiquan XuShuangxin LiuPublished in: Nephrology (Carlton, Vic.) (2024)
Pregnant IgAN patients with higher risks, including lower haemoglobin levels and higher IgM levels deserve intensive monitoring, and aggressive therapy to reduce proteinuria should be carried out in pregnant IgAN patients with APO.